Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

INTRODUCTION: Treatment advances in metastatic renal cell carcinoma (mRCC) have improved overall survival (OS) in mRCC patients over the last two decades. This single center retrospective analysis assesses if the purported survival benefits are also applicable in elderly mRCC patients. METHODS: 401...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggers, Hendrik, Schünemann, Christoph, Grünwald, Viktor, Rudolph, Linda, Tiemann, Maria-Luisa, Reuter, Christoph, Anders-Meyn, Merle Freya, Ganser, Arnold, Ivanyi, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512722/
https://www.ncbi.nlm.nih.gov/pubmed/35916904
http://dx.doi.org/10.1007/s00345-022-04110-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512722/
https://www.ncbi.nlm.nih.gov/pubmed/35916904
http://dx.doi.org/10.1007/s00345-022-04110-3

Ejemplares similares